Each horizontal bar represents the distribution (in percentage) of physicians’ estimates for a given drug-indication group. TURN* corresponds to the frequency of missing doses above which 75% of physicians’ estimates were located (vertical dashed line). n* corresponds to the number of physicians’ assessments for each drug-indication group. For sake of clarity, we plotted 70 drug-indication groups corresponding to 90% of total prescription volume of the medications assessed in the study. All the 112 drug-indication groups are plotted in S2 Fig. Abbreviations: ACE: angiotensin-converting enzyme, ARBs: angiotensin receptor blockers, CCBs: calcium channel blockers; COPD: Chronic Obstructive Pulmonary Disease; GORD: gastro-oesophageal reflux dis...
Mark Lemstra, M Wasem Alsabbagh Academic Family Medicine, College of Medicine, University of Saskatc...
<p>Figure 1 shows the distribution of the estimated cardiovascular disease (CVD) burden of disease (...
<p>Abbreviations: CCB; calcium channel blocker, ACE-I; angiotensin-converting enzyme inhibitor, ARB;...
TURN* corresponds to the frequency of missing doses above which 75% of physicians’ estimates were lo...
BackgroundAchieving good medication adherence is a major challenge for patients with chronic conditi...
<p>Abbreviations: RR, rate ratio; CI, confidence interval; ARB, angiotensin receptor blocker; ACEI, ...
<p>Prescriptions for adult (age >18 yrs).</p><p>Metabolism, Metabolism & endocrinology; Gen Med, Gen...
Distribution of patients according to the pattern of medication adherence to anti-diabetic drugs.</p
<p>Abbreviations: CI, confidence interval; ACE, angiotensin converting enzyme; ARB, angiotensin rece...
□ represents unadjusted odds ratios; ∎ represents adjusted odds ratios; GLD: glucose lowering drugs;...
p.831-836The aim of this study was to use indicators to evaluate physician adherence to prescription...
Background: In pharmacotherapy, the achievement of a target clinical outcome requires a certain leve...
<p>Co-prescribed drugs categorized by drug class for all adults in the 2009–2010 NHANES dataset. For...
Objective: To investigate the antihypertensive prescribing patterns among physicians at KAMC-R. M...
a Distribution of all co-medication pairs (left) and dosage-adjusted co-medication pairs (with ORs >...
Mark Lemstra, M Wasem Alsabbagh Academic Family Medicine, College of Medicine, University of Saskatc...
<p>Figure 1 shows the distribution of the estimated cardiovascular disease (CVD) burden of disease (...
<p>Abbreviations: CCB; calcium channel blocker, ACE-I; angiotensin-converting enzyme inhibitor, ARB;...
TURN* corresponds to the frequency of missing doses above which 75% of physicians’ estimates were lo...
BackgroundAchieving good medication adherence is a major challenge for patients with chronic conditi...
<p>Abbreviations: RR, rate ratio; CI, confidence interval; ARB, angiotensin receptor blocker; ACEI, ...
<p>Prescriptions for adult (age >18 yrs).</p><p>Metabolism, Metabolism & endocrinology; Gen Med, Gen...
Distribution of patients according to the pattern of medication adherence to anti-diabetic drugs.</p
<p>Abbreviations: CI, confidence interval; ACE, angiotensin converting enzyme; ARB, angiotensin rece...
□ represents unadjusted odds ratios; ∎ represents adjusted odds ratios; GLD: glucose lowering drugs;...
p.831-836The aim of this study was to use indicators to evaluate physician adherence to prescription...
Background: In pharmacotherapy, the achievement of a target clinical outcome requires a certain leve...
<p>Co-prescribed drugs categorized by drug class for all adults in the 2009–2010 NHANES dataset. For...
Objective: To investigate the antihypertensive prescribing patterns among physicians at KAMC-R. M...
a Distribution of all co-medication pairs (left) and dosage-adjusted co-medication pairs (with ORs >...
Mark Lemstra, M Wasem Alsabbagh Academic Family Medicine, College of Medicine, University of Saskatc...
<p>Figure 1 shows the distribution of the estimated cardiovascular disease (CVD) burden of disease (...
<p>Abbreviations: CCB; calcium channel blocker, ACE-I; angiotensin-converting enzyme inhibitor, ARB;...